Chloroquine as Antiviral Treatment in Coronavirus Infection 2020

Summary

The aim of the study is to evaluate whether the therapy with chloroquine phosphate (CQ, in combination with telemedical approach) in addition to standard care is effective and safe in reducing composite endpoint of COVID-19-related hospitalization or all cause death, in ambulatory patients with SARS-SoV-2 infection at particular risk of serious complications due to advanced age and/or comorbid conditions (in comparison with subjects not treated with CQ but receiving standard care and supervised telemedically).

Timeline

Start

2020-04-16

Primary completion

2020-12-17

Completion

2020-12-17

Drugs

Indications